IPO

overview Solid Biosciences: promising biotechnology company

Solid Biosciences (Nasdaq: SLDB) a biotechnology company based in Cambridge, Massachusetts, which is engaged in the search for new methods of therapy for genetic diseases and the development of appropriate medicines. The business was founded in 2013 and went public in 2018 after listing shares on Nasdaq.

Ratchet, Clank and TVs: investing in Sony

Sony (NYSE: SONY) - the legendary Japanese conglomerate. The company makes its equipment, video games, films. But she also has problems.: debt and Microsoft. When creating the material, sources were used, inaccessible to users from the Russian Federation. We hope, Do you know, what to do.

Investidea: Affirm, because it's time

Today we have an extremely speculative idea.: take shares of the installment service Affirm (NASDAQ: AFRM), in order to make money on the rebound of these shares. Growth potential and validity: 22% behind 12 Months; 67% behind 3 of the year. Why stocks can go up: because they fell hard. How do we act: we take shares now by 42,31 $. When creating the material, sources were used, inaccessible to users from the Russian Federation. We hope, Do you know, what to do. Without guarantees Our reflections are based on the analysis of the company's business and the personal experience of our investors, but remember: not a fact, that the investment idea will work like this, as we expect. Everything, what we write, are forecasts and hypotheses, not a call to action. To rely on our reflections or not – it's up to you. And what is there with the forecasts of the author of the Study, like this and this, talk about, that the accuracy of target price predictions is low. And that's ok: there are always too many surprises on the stock exchange and accurate forecasts are rarely realized. If the situation were reversed, then funds based on computer algorithms would show results better than people, but alas, they work worse. So we're not trying to build complex models.. The profitability forecast in the article is the author's expectations. We specify this forecast for the landmark. As with the investment idea in general, readers decide for themselves, it is worth trusting the author and focusing on the forecast or not. We love, appreciate,Investment Edition How the company makes money This is an American fintech installment payment service. We have published a detailed review of the company's business, so let's not repeat ourselves. Highlight the main points: The company is unprofitable. In the West, the idea of installments seems to consumers and investors very innovative and unusual.. Affirm receives the main revenue, collecting commissions from the flow of payments on its platform. And more payments — …

Investidea: Affirm, because it's time Read more

Investidea: Graham Holdings, because Buffett approves

Today we have a moderately speculative idea.: take shares of Graham Holdings (NYSE: GHC), in order to make money by discovering their hidden value. Growth potential and validity: 13,5% behind 14 Months; 25,5% behind 3 of the year; 10% per annum during 15 years. All excluding dividends.

Scroll to Top